Conference Presentation Details - Overview
Rapid Reviews in Oncology: Breast Cancer Highlights
Release Date: January 20, 2010|
Expiration Date: January 20, 2011
2 AMA PRA Category 1 Credit(s)™|
Dec 16, 2009, Dallas, TX
Learning Objectives
Upon completion of this educational activity, you should be able to:
- Assess genomic and proteomic tools for the estimation of recurrence risk, prediction of benefit from chemotherapy, and individualization of therapeutic decision making
- Evaluate adjuvant endocrine options for postmenopausal patients, including timing and sequencing of aromatase inhibitors in adjuvant regimens and the integration of bone-targeted agents
- Individualize the management of patients with chemotherapy-refractory advanced breast cancer, including the incorporation of novel biologic and cytotoxic agents
- Review novel classes of targeted biologic agents and cytotoxic therapies currently under investigation for the treatment of metastatic breast cancer
- Assess available and investigational agents for improving bone health in patients receiving endocrine treatment for breast cancer
- Select eligible patients for promising clinical trials
Choose a Participation Option
To claim credit for this activity you must:
- Take the Pretest
- Participate in the Activity
- Take the Posttest
- Take the Evaluation
- Claim your Credit Amount & Certificate Type
If you do not wish to claim credit:
You may bypass all CE information, tests and evaluations and go straight to the activity.
You may not request credit after viewing the activity.
I wish to participate in this
activity and claim credit.
I wish to view the activity
without claiming credit.